Top Pharmaceutical and Life Science Events in September (2022)
Top Pharmaceutical and Life Science events taking place in September 2022, including Biotechnology, Clinical Research, Drug Discovery and Medical Device events.
3rd Operationalize: Decentralized Clinical Trials (September 7th-8th)
Join over 150 DCT leaders to hear exclusive case-studies and engage in open discussions offering practical, implementable, and grounded insights. This is your best opportunity to clarify the complex issues through end-to-end hybrid and siteless clinical trial program operationalization.
Intelligent Health AI (September 7th-8th)
This event will once again bring together the global AI and health community in Basel this September to advance discussions on how AI can be used to prevent and solve some of the world’s greatest healthcare problems and improve the health of the human race.
Euro Global Conference on Proteomics, Genomics and Bioinformatics (September 12th-13th)
This event will take place in a hybrid manner at Paris, France and virtually, and will emphasize the theme “Envisioning the Future and Exploring All Facets of Proteomics, Genomics and Bioinformatics.”
Clinical Risk Management for Emerging Companies (September 12th-14th)
This conference will go back to basics and the building blocks of an effective clinical quality foundation, breaking down the critical components to the bare minimum. The format will be geared towards more tactile learning.
Re:Imagine Medical Device Marketing (September 13th-14th)
This conference will acknowledge the major setbacks medical device marketers have to worry about moving forward from COVID-19, including supply chain shortages, the minimal adoption of invasive devices, wearable technology, and the rise of outsourcing.
3rd Gene Therapy for Ophthalmic Disorders (September 13th-16th)
Join 40+ speakers from the industry leaders in ophthalmic gene therapy such as Novartis, Janssen, Adverum, REGENXBIO, Kriya and many more as we discover novel vector engineering, disease models, clinical trials design, patient enrolment platforms and more.
3rd Edition of Cardiology World Conference (September 14th-15th)
The summit is open to all outstanding professional scientists, researchers, cardiologists, heart specialists, healthcare professionals, surgeons, industry giants and devoted students to discuss a variety of cardiac ailments, their diagnosis, treatment, and prevention.
2nd MSL Best Practices Summit (September 14th-15th)
The summit will focus on the Evolution of the role, the right use of metrics and the value they need to have when it comes to measuring the MSL function, involvement in clinical trials, KOL engagement, building the right MSL team and investing in educating and preparing your MSLs for value interactions.
Connect in Pharma (September 14th-15th)
The Sustainable Medicines Packaging Awards showcase and celebrate sustainable innovations revolutionising pharmaceutical packaging today. The awards are run by sustainable healthcare pioneers YewMaker, with winners announced at this in-person champagne ceremony.
Network Pharma: Working in and Around #MedComms (September 19th)
You’ll have the opportunity to meet with lots of specialists from across the MedComms community, including people working in and around Medical Communications, Medical Education and Medical Publishing who will be there to help explain the many career opportunities available to you, and to guide you on your next steps.
Fierce Biotech Summit (September 19th-20th)
A two-day conference in Boston, MA, covering drug development from the earliest stage of research to FDA approval. It will spotlight the many players involved in getting a drug from the lab to the pharmacy.
Fierce New Product Planning Summit (September 19th-20th)
The summit will reinforce the product development and create value, encourage strategic product development, and gain insights into achieving key stakeholder buy-in to execute a successful launch and commercialization of new products.
Reuters Events: Cell and Gene Therapy USA (September 20th-21st)
Pioneer a gold standard for CGT commercialization. Co-create a commercial toolkit that enables suitable, scalable, and sustainable growth. Join 1500+ CGT leaders pioneering a new gold standard for commercialization, readying the world for CGT as a frontline treatment.
13th Annual World Bispecific Summit (September 20th-22nd)
The summit will deliver a greater scope and penetration of innovative technical content than any other meeting. This year’s re-imagined agenda will cover unique target discovery, mechanistic diversity and translational science as well as novel formats, product design and manufacturability challenges faced in the bispecific field.
Global Clinical Trials Connect (September 21st-22nd)
This conference will provide a platform to discuss the futuristic advancements in clinical trials and clinical research. Its multidisciplinary program involves broad participation of people from the clinical trials community from around the globe.
2022 Pharma CI USA Conference & Exhibition (September 21st-22nd)
The best and largest assembly of competitive intelligence executives in pharma, biotech, and medical devices for 15+ years! The conference and exhibition is the gold standard for senior-level industry professionals who seek the latest in competitive and business intelligence.
International Human Gene Therapy Conference (September 26th-28th)
The aim of the conference is to bring together all the key stakeholders interested in genetics and gene therapy to share and discuss advances and developments in these fields.
4th Annual RAS Targeted Drug Development Summit (September 26th-28th)
The summit returns as the definitive industry dedicated forum for the whole community of individuals committed to targeting RAS. This year’s forum returns as the only industry-focused event wholly dedicated to RAS-mutant cancers.
6th Complement-based Drug Development Summit (September 27th-29th)
The summit returns to reunite large pharma, innovative biotechs and pioneering academics to explore the full range of next generation complement-targeted technologies, and help you maximize the clinical and commercial success of complement proteins as pain-disease targets.